Portal hypertension should not be a contraindication of hepatic resection to treat hepatocellular carcinoma with compensated cirrhosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|62|3|977-978

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.62, Iss.3, 2015-09, pp. : 977-978

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hepatocellular carcinoma with hepatic vein invasion should not be considered a contraindication for liver resection

By  

HEPATOLOGY, Vol. 67, Iss. 2, 2018-02 ,pp. : 804-805

John Wiley & Sons Inc

Access to resources Recommend Favorite

Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysis

By  

HEPATOLOGY, Vol. 61, Iss. 2, 2015-02 ,pp. : 526-536

John Wiley & Sons Inc

Access to resources Recommend Favorite

Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysis. More doubts than clarity

By  

HEPATOLOGY, Vol. 62, Iss. 3, 2015-09 ,pp. : 976-977

John Wiley & Sons Inc

Access to resources Recommend Favorite

Should surgery be carried out in patients with hepatocellular carcinoma with portal hypertension?

By  

HEPATOLOGY, Vol. 62, Iss. 3, 2015-09 ,pp. : 976-976

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is There a Role for Adjuvant Treatment after Hepatic Resection for Hepatocellular Carcinoma?

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 161-171

Karger

Access to resources Recommend Favorite